Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.77 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.77 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.77 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.57 |
| ▸ | GAA | P10253 | 3/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | THRB | P10828 | 1/20 | 0.54 |
| ▸ | G6PD | P11413 | 1/20 | 0.54 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 4/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28273434 | 0.98 | HSD17B10 (0.80) | HSD17B10ALOX15CYP2C9CYP2C19MAPK1 | |
| SCHEMBL36297 | 0.98 | HSD17B10 (0.80) | HSD17B10ALOX15CYP2C9CYP2C19MAPK1 | |
| SCHEMBL25305838 | 0.95 | HSD17B10 (0.77) | HSD17B10ALOX15CYP2C9CYP2C19MAPK1 | |
| Ammonia Solution, Strong SCHEMBL4827174 | 0.95 | HSD17B10 (0.77) | HSD17B10ALOX15CYP2C9CYP2C19MAPK1 | |
| SCHEMBL25306052 | 0.95 | HSD17B10 (0.77) | HSD17B10ALOX15CYP2C9CYP2C19MAPK1 | |
| Dimethylamine SCHEMBL28105045 | 0.91 | HSD17B10 (0.71) | HSD17B10ALOX15CYP2C9CYP2C19MAPK1 | |
| SCHEMBL13038516 | 0.87 | HSD17B10 (1.00) | HSD17B10ALOX15CYP2C9CYP2C19MAPK1 | |
| SCHEMBL11406770 | 0.86 | HSD17B10 (0.64) | HSD17B10ALOX15CYP2C9CYP2C19MAPK1 | |
| Thiocyanic Acid SCHEMBL5827196 | 0.86 | HSD17B10 (0.65) | HSD17B10ALOX15CYP2C9CYP2C19MAPK1 | |
| SCHEMBL2879776 | 0.86 | ALOX15 (0.65) | HSD17B10ALOX15CYP2C9CYP2C19MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4204474-A1 | THERMALLY CURABLE COMPOSITIONS, THERMALLY CURED COMPOSITIONS, AND ARTICLES PREPARED THEREFROM | 3M Innovative Properties Company (US) | 2023-07-05 | — | — | EP | claimed |
| US-12545782-B2 | Thermally curable compositions, thermally cured compositions, and articles prepared therefrom | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2026-02-10 | — | — | US | disclosed |
| US-20230279216-A1 | THERMALLY CURABLE COMPOSITIONS, THERMALLY CURED COMPOSITIONS, AND ARTICLES PREPARED THEREFROM | 3M INNOVATIVE PROPERTIES COMPANY | 2023-09-07 | — | — | US | disclosed |
| EP-4204474-A1 | THERMALLY CURABLE COMPOSITIONS, THERMALLY CURED COMPOSITIONS, AND ARTICLES PREPARED THEREFROM | 3M Innovative Properties Company (US) | 2023-07-05 | — | — | EP | disclosed |
| US-5470896-A | Storage-stable solutions of accelerator systems | CIBA-GEIGY CORPORATION (US) | 1995-11-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12545782-B2 | Thermally curable compositions, thermally cured compositions, and articles prepared therefrom | TERT, ARCN1, MRPL12 | HSD17B10 4167/4885ALOX15 1067/4885CYP2C9 4753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.